fujitsu

Fujitsu – Faster disease diagnosis using computer software

  • by

A large amount of information in Electronic Health Records (EHRs) is available in the form of free-text narratives, such as discharge summaries, physician notes, nurse notes etc.  Medical professionals spend significant time understanding these notes, which can lead to delayed diagnosis. It is also common for the interaction between doctors and patients to be incompletely documented, which can sometimes negatively impact treatment. Thus, there is a need for automated tools… Read More »Fujitsu – Faster disease diagnosis using computer software

Fujitsu – Techniques to aid in drug discovery

  • by

The process of designing a pharmaceutical product using a computer (also known as computational drug discovery) can be an effective tool in increasing the probability of and reducing the time period for developing new drugs. Especially relevant in the fight against the pandemic, the patent claims a method that can be used to design new drugs. In particular, it discusses methods for identifying the binding site of a target molecule.… Read More »Fujitsu – Techniques to aid in drug discovery

Top Patent Holders Make Open COVID Pledge

According to statistics recently released by the Intellectual Property Owners (IPO), companies making the Open COVID Pledge were among the top acquirers of U.S. patents last year.  IBM, the #1 patent holder, was issued nearly 9,500 patents in 2019.  Open COVID Pledge makers Intel, Microsoft, Amazon, AT&T, Facebook, Fujitsu and HP Enterprise also place prominently on the list. We congratulate these firms for their commitment to putting their substantial intellectual… Read More »Top Patent Holders Make Open COVID Pledge

Fujitsu makes the Open COVID Pledge and frees its IP to end the pandemic

The Open COVID Coalition is pleased to announce that Fujitsu Limited has made the Open COVID Pledge, freeing its intellectual property to end the COVID-19 pandemic. Fujitsu, one of the world’s leading technology companies, holds approximately 40,000 issued and pending patents, utility models, and design patents related to the development of new drugs and patient care. Fujitsu has also endorsed and declared its involvement with the Open COVID-19 Declaration, a… Read More »Fujitsu makes the Open COVID Pledge and frees its IP to end the pandemic